FDA Budget Limits Mean Personnel Cuts Likely; 15% Reduction in Admin
The Center for Drug Evaluation & Research will likely cut administrative and information technology personnel to meet fiscal year 2004 budget constraints, Director Janet Woodcock, MD, says
You may also be interested in...
The comparative trial/cost effectiveness provisions in the Medicare legislation will require a supplemental appropriation for the Agency for Healthcare Research & Quality
The Medicare prescription drug coverage legislation should help FDA make the case for additional funding for post-marketing surveillance, according to Center for Drug Evaluation & Research Acting Director Steven Galson, MD
Center for Drug Evaluation & Research Deputy Director Steve Galson, MD, will be acting center director during the period when FDA is expected to announce a decision on forced Rx-to-OTC switches